Viking Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:1VT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
30 Jul 24	Sell€6,174,978	Brian Lian	Individual	115,859	€54.41
30 Jul 24	Sell€953,390	Marianne Mancini	Individual	18,026	€53.52
30 Jul 24	Sell€853,692	Gregory Zante	Individual	16,136	€54.35
04 Jan 24	Sell€245,006	Gregory Zante	Individual	15,000	€16.33

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1VT?
Owner Type	Number of Shares	Ownership Percentage
State or Government	45,950	0.0412%
Individual Insiders	2,315,157	2.08%
Public Companies	3,616,077	3.24%
General Public	22,365,479	20.1%
Institutions	83,093,721	74.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.4%.

Top Shareholders

Top 25 shareholders own 57.25% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.9%	FMR LLC	16,619,430	€680.7m	0.48%	0.04%
9.12%	The Vanguard Group, Inc.	10,167,614	€416.4m	0.7%	0.01%
4.83%	BlackRock, Inc.	5,380,323	€220.4m	-10.7%	no data
4.19%	State Street Global Advisors, Inc.	4,674,067	€191.4m	-8.75%	0.01%
3.24%	Ligand Pharmaceuticals Incorporated	3,616,077	€148.1m	0%	no data
1.82%	JP Morgan Asset Management	2,032,024	€83.2m	-4.23%	0.01%
1.71%	Brian Lian	1,909,371	€78.2m	2.06%	no data
1.67%	Geode Capital Management, LLC	1,863,667	€76.3m	0.25%	0.01%
1.55%	Morgan Stanley, Investment Banking and Brokerage Investments	1,721,929	€70.5m	111%	0.01%
1.53%	Perceptive Advisors LLC	1,699,987	€69.6m	136%	1.68%
1.32%	Citadel Advisors LLC	1,472,676	€60.3m	216%	0.07%
1.22%	Pictet Asset Management Limited	1,361,510	€55.8m	-1.44%	0.05%
1.04%	Braidwell LP	1,156,977	€47.4m	4.52%	2.2%
1%	Susquehanna International Group, LLP, Asset Management Arm	1,115,105	€45.7m	-20.6%	0.08%
1%	J O Hambro Capital Management Limited	1,111,095	€45.5m	54.9%	0.41%
0.93%	AllianceBernstein L.P.	1,033,885	€42.3m	-16.7%	0.01%
0.83%	Westfield Capital Management Company, L.P.	930,370	€38.1m	18.3%	0.17%
0.78%	Invesco Ltd.	865,267	€35.4m	24.2%	0.01%
0.73%	Hood River Capital Management LLC	815,678	€33.4m	14.2%	0.52%
0.72%	UBS Asset Management AG	801,203	€32.8m	-4.48%	no data
0.66%	ClearBridge Investments, LLC	738,574	€30.2m	26.3%	0.02%
0.65%	Viking Global Investors LP	721,926	€29.6m	-46.7%	0.1%
0.64%	Charles Schwab Investment Management, Inc.	715,597	€29.3m	6.57%	no data
0.6%	Voya Investment Management LLC	674,139	€27.6m	8.31%	0.03%
0.53%	Principal Global Investors, LLC	593,734	€24.3m	30%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/27 22:17
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Viking Therapeutics, Inc. is covered by 25 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Matthew Luchini	BMO Capital Markets Equity Research
Mayank Mamtani	B. Riley Securities, Inc.
Julian Harrison	BTIG